Home

Hubert Birner

CIK 1398598 · last filed 2018-06-11

Hubert Birner is a corporate insider who has filed 19 SEC Form 4 insider transactions across 5 companies since 2011. The most recent filing, for PRTO, was dated Jun 11, 2018. Across all open-market trades the lifetime net is −$157.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $58.8M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$58.82M

Companies

5

Total Filings

19

Lifetime Open-Market Net

-$157.08M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
PRTO Director 1,903,127 $27.53 $52.39M $3.00M 6 2018-06-11
ARGOS THERAPEUTICS INC (ARGS) Delisted Director 1,943,013 — — $319.0K 10 2017-01-20
ENTA 10%+ Owner 459,064 $14.00 $6.43M -$170.53M 1 2014-03-07
CONCERT PHARMACEUTICALS, INC. (CNCE) Delisted 10%+ Owner 1,245,736 $8.37 $10.43M $8.72M 1 2014-02-20
Horizon Therapeutics Public Ltd Co (HZNP) Delisted Director 409,116 $116.30 $47.58M $1.41M 1 2011-08-04

Recent Filings

19 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2018-06-11 PRTO Grant (A) — $0 EDGAR
2017-06-30 PRTO Buy (P) — $0 EDGAR
2017-06-21 PRTO Grant (A) — $0 EDGAR
2017-01-20 ARGOS THERAPEUTICS INC (ARGS) Delisted Grant (A) — $0 EDGAR
2017-01-04 ARGOS THERAPEUTICS INC (ARGS) Delisted Grant (A) +3,571 $0 EDGAR
2016-10-03 ARGOS THERAPEUTICS INC (ARGS) Delisted Grant (A) +3,521 $0 EDGAR
2016-07-05 ARGOS THERAPEUTICS INC (ARGS) Delisted Grant (A) +2,854 $0 EDGAR
2016-07-01 ARGOS THERAPEUTICS INC (ARGS) Delisted Buy (P) +275,545 $0 EDGAR
2016-06-15 PRTO Grant (A) — $0 EDGAR
2016-06-14 ARGOS THERAPEUTICS INC (ARGS) Delisted Grant (A) — $0 EDGAR
Showing 1–10 of 19
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.